KPV (Lys-Pro-Val) Peptide is a short, synthetic tripeptide consisting of the amino acids lysine (K), proline (P), and valine (V). It is the C-terminal fragment (active sequence) of alpha-melanocyte-stimulating hormone (α-MSH), a naturally occurring peptide hormone involved in regulating inflammation, immune responses, and other processes. Unlike the full α-MSH, KPV retains potent anti-inflammatory and immune-modulating properties but lacks the melanotropic (skin-darkening) effects.

KPV is researched primarily for its ability to modulate inflammatory pathways without the side effects associated with steroids or broader immunosuppressants. It works by inhibiting pro-inflammatory cytokines (e.g., TNF-α, IL-6, IL-1β), suppressing NF-κB signaling, reducing leukocyte activation, and supporting tissue repair. This makes it a candidate for conditions involving chronic or localized inflammation.

Key Features and Potential Uses

• Primary Mechanism: Potent anti-inflammatory and immunomodulatory effects, often more targeted than the parent α-MSH. It promotes balance in immune responses, antimicrobial activity, and healing without broad hormonal disruption.
• Administration Forms (based on research and compounding availability):
  • Oral (capsules or tablets) — especially for gut-targeted effects.
  • Nasal spray — for potential systemic or neurological absorption.
  • Injectable (subcutaneous) — for broader systemic benefits.
  • Topical (creams/gels) — for skin applications.
• Onset and Duration: Effects can vary by route; oral and nasal forms are convenient and needle-free, with research showing good bioavailability in targeted areas like the gut.
• Typical Research/Compounded Dosing (from sources; not medical advice): Often 250–500 mcg orally/sublingually daily, or 0.5–2 mg injectable, adjusted based on response. Cycles are short-term or as needed, with limits to avoid tolerance.

Potential Benefits

• Anti-Inflammatory Effects: Reduces systemic and localized inflammation; studied for chronic conditions like arthritis, autoimmune issues, and post-viral symptoms (e.g., long COVID).
• Gut Health Support: Promotes intestinal barrier integrity, mucosal repair, reduces colitis/inflammation in models of IBD (e.g., ulcerative colitis), and supports microbiome balance.
• Skin Repair and Wound Healing: Accelerates healing, reduces inflammation in conditions like eczema, psoriasis, acne, or wounds; shows promise in dermatological models.
• Immune Modulation and Antimicrobial: Helps regulate immune responses, with reported antimicrobial properties (e.g., against bacteria/fungi) and potential in autoimmune or infection-related inflammation.
• Other Areas: Recovery from injuries, tissue regeneration, and emerging interest in neuroprotective or anti-cancer supportive roles (preclinical).

Potential Side Effects

KPV is generally well-tolerated in research, with few notable side effects reported (often milder than alternatives like corticosteroids). Possible mild issues include injection-site reactions (if injectable), transient flu-like symptoms, or minor gastrointestinal upset. Long-term human data is limited, as much evidence comes from preclinical/animal studies and early clinical observations.

Note: KPV is not FDA-approved for any medical use and is typically available through compounding pharmacies or research suppliers (often as “research peptide”). It’s used off-label in functional/regenerative medicine for inflammation-related issues.

Always consult a qualified healthcare professional before considering any peptide therapy, as individual responses vary, and proper sourcing, dosing, and monitoring are essential for safety. Research is promising but ongoing, with more human trials needed for definitive claims.